The Complexities of Defective Drug Lawsuits: Holding Pharmaceutical Companies Liable

Novo Nordisk and Eli Lilly, known for their significant revenues from GLP-1 diabetes and obesity medications, are preparing to defend against legal actions brought by recent consumers. One particular case involves a woman from Louisiana who has filed a lawsuit against both pharmaceutical companies. She asserts her consumption of Novo’s Ozempic (semaglutide) and Lilly’s Mounjaro …